PMA device
TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System
Cerenovus, Inc. · Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations (KGG, Class III) · First FDA decision Sep 25, 2000, newest Jul 2, 2024Brain bleeding (hemorrhagic stroke)
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
1
Naming "TRUFILL n-Butyl Cyanoacrylate"
MAUDE reports
0
Brand "TRUFILL n-Butyl Cyanoacrylate", since 2015
PubMed studies
6
Mentioning "TRUFILL n-Butyl Cyanoacrylate"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 9 decisions filed under this name.
FDA's records could not be loaded.
Older decisions: P990040-S009, P990040-S001, P990040
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TRUFILL n-Butyl Cyanoacrylate", any status and sponsor, newest update first.
- Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCAPivotal-lookingCompleted
Cerenovus, Part of DePuy Synthes Products, Inc.Not on our public-company list
NCT04816591 · 376 participants · Start May 27, 2021 · Primary completion Aug 15, 2024
Device: Experimental: Interventional Cohort: TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System; Experimental: Interventional Cohort: TRUFILL n-BCA Liquid Embolic System · For: Chronic Subdural Hematoma
Sites: Birmingham, Alabama; Tucson, Arizona; Walnut Creek, California · 33 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TRUFILL n-Butyl Cyanoacrylate", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KGG
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TRUFILL n-Butyl Cyanoacrylate"[tiab]. The summary above synthesizes these.
- Middle Meningeal Artery Embolization With n-Butyl Cyanoacrylate in Patients With Chronic Subdural Hematoma: A Randomized Clinical Trial.
Kellner CP, Rai AT, Shoirah H, et al. · JAMA Neurol · 2026Randomized Controlled Trial, Multicenter Study
- Consensus Statement on Middle Meningeal Artery Embolization in Chronic Subdural Hematoma Treatment: A Guideline from the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.
Siddiq F, Shakir M, Nguyen TN, et al. · Stroke Vasc Interv Neurol · 2025Review
- Treatment of Bronchopleural Fistulas in Coronavirus Disease 2019 With Coils, Glue, and an Amplatzer Vascular Plug.
Toussaint A, Kang F, Nosher J, et al. · Ann Thorac Surg Short Rep · 2025Case Reports
- Middle Meningeal Artery Embolization with n-Butyl Cyanoacrylate for the Treatment of Subdural Hematomas: The MEMBRANE Study Design.
Kellner CP, Al-Mufti F, Gupta R, et al. · Stroke Vasc Interv Neurol · 2025
- Endovascular Embolization of Intracranial Infectious Aneurysms in Patients Undergoing Open Heart Surgery Using n-Butyl Cyanoacrylate.
Cheng-Ching E, John S, Bain M, et al. · Interv Neurol · 2017
- US FDA perspective on the regulations of medical-grade polymers: cyanoacrylate polymer medical device tissue adhesives.
Mattamal GJ · Expert Rev Med Devices · 2008
Other devices of this type
Also filed under product code KGG.
- TRUFILL n-BCA Liquid Embolic SystemCerenovus, Inc. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.